PR.com is a leader in paid and free press release distribution.
To reach journalists, increase online visibility, and attract new customers,
submit via our global online news and press release distribution service to
top search engines, thousands of websites, social media, blogger networks,
as well as via print, broadcast, radio, mobile channels, and more.
Ensure loved ones diagnosed or at greater risk of diabetes schedule an annual eye exam. - November 15, 2017 - MyEyeDr.
Thomas Morizio, former President and CEO of ACIST Medical System and HLT, joins RxFunction, Inc. Morizio brings more than 31 years of extensive medical device business leadership experience to RxFunction. - November 09, 2017 - RxFunction.com
Ernest Quansah, type 2 diabetes survivor, cure expert and founder of Discover Diabetes Self-Cure says, "We are very excited to launch this website to help diabetics and pre-diabetics heal. My own story about how my diabetes type 2 was cured was featured in the WebMD Diabetes, fall 2016 issue, page 19." WebMD is the largest health-information provider to doctors and the healthcare industry. - November 01, 2017 - Discover Diabetes Self-Cure
Medical device manufacturers will have the opportunity to discover CleanCut Technologies’ innovative line of custom medical device packaging products in Booth #529 at the BIOMEDevice 2017 Show on December 6-7 at the San Jose Convention Center.
CleanCut Technologies continues its effort to design... - October 30, 2017 - CleanCut Technologies
Multiplex assays have been plagued by a lack of specificity and accuracy, with unreliable data as a result. However, a new multiplex assay has reached the US market. Mercodia, based in Sweden, has teamed-up with Quansys Biosciences, based in the US, to launch the AKURIO Islet Hormones multiplex assay, which measures four of the most notable hormones in pancreatic research: glucagon, insulin, C‑peptide and proinsulin. - October 27, 2017 - Mercodia AB
Fiber Pasta U.S., the innovative and healthy pasta company, officially launched the PastaPro, Pasta for Fitness. - October 20, 2017 - FiberPasta
Time to pull out your favorite school shirt and get ready for a day of school spirit as AirTime Trampoline & Park is kicking off the new school year with School Pride to benefit JDRF (Juvenile Diabetes Research Foundation) on Thursday, September 28, 2017 at all locations in Troy, Sterling Heights,... - September 18, 2017 - AirTime Trampoline & Game Parks
“It helped my balance!,” “Gave me more confidence, I felt stronger!,” “No dizziness at all, like something was suppressing dizziness!,” “Made me feel like a normal person!,” are statements from participating Veterans in a study of Walkasins at the Minneapolis VA. - September 14, 2017 - RxFunction.com
Can their mission to create awareness about the benefits of Miracle Fruit reach those who need it most? - August 16, 2017 - Miracle Fruit Farm
Dr. Madeira cuts out health insurance companies to provide functional and naturopathic medical care to his patients for affordable membership monthly fee. - August 15, 2017 - Apollo Health Clinic
Computer Science Assoc. Prof. Juan Li is the principal investigator for a newly announced grant from the National Science Foundation to study self-management of diabetes in Native Americans, along with co-investigator and Computer Science Assoc. Prof. Jun Kong. Siobhan Wescott, a NDSU Asst. Prof. of... - August 02, 2017 - NDSU Computer Science
Rich Creations, LLC is proud to release an all-natural caffeine-free liquid supplement and cognitive enhancer, Rich Recovery™. Now available to the market to serve as a healthy energetic alternative for people with dietary restrictions, such as diabetics and high blood pressure. - July 06, 2017 - Rich Creations, LLC
The STELLUX® Chemiluminescent Plate Reader offers a simple plug-and-play setup, and is the ideal size for any lab. ALPCO’s Field Applications Scientist will be on-site at the ADA’s 77th Scientific Sessions offering live demonstrations of the new STELLUX® Chemiluminescent Plate Reader. - June 07, 2017 - ALPCO
In an effort to help kids understand their type 1 diabetes diagnosis, Ascensia Diabetes Care and health education company Jumo are teaming up to create engaging, creative, and age-appropriate materials for kids.
Sponsored by Ascensia Diabetes Care, Jumo, through its signature comic book line and superhero... - June 07, 2017 - Jumo
ALPCO and InSphero will team up at the ADA’s 77th Scientific Sessions to enhance the study of islet function, regeneration, and preservation by providing researchers with methods to perform 3D islet microtissue culture, as well as assays for measuring glucagon secretion and glucose-regulated insulin assays. - June 06, 2017 - ALPCO
Medicare has issued new rules for sleep centers in California, Nevada and Hawaii requiring accreditation by a national accrediting body effective June 5, 2017. Advanced Sleep Medicine Services, Inc., the leading provider of sleep testing services and PAP therapeutic devices in Southern California, is fully accredited and meets all the requirements of the new rules. - May 31, 2017 - Advanced Sleep Medicine Services, Inc.
In order to better understand the impact of "Lifestyle Therapy" on diabetes treatment and patient outcomes, a comprehensive longitudinal cohort study is being jointly developed by Kantar Health and Nokia. The novel combination of biometric and longitudinal, real-world data will drive better consumer insights through a holistic, 360-degree view of the diabetes patient. - May 22, 2017 - Kantar Health
“I put them on, and it was like a miracle,” says neuropathy sufferer and study subject, Mr. Tim Kelley. Walkasins work by restoring sensory signals that are not functioning normally in patients with neuropathy. This immediate restoration of sensory function also impressed Dr. Diane Wrisley of Wingate University. “His brain learned to use the Walkasins immediately," says Wrisley. "He put them on and it was like, ‘Wow! I know where I am in space.’ His improvement is phenomenal.” - May 10, 2017 - RxFunction.com
The Medical Center of Aurora (TMCA) announced today that they are partnering with Project Angel Heart in a groundbreaking pilot program whereby TMCA dietitians will help discharged patients connect with Project Angel Heart, who will then provide healthy meals to those patients for 30 days following their... - May 03, 2017 - The Medical Center of Aurora
GenoScribe by Emgenex is an extensive and unprecedented pharmacogenetic testing service to help providers personalize treatment and medications based on a patient's genetics. Now the offering of GenoScribe Live software is going beyond pharmacogenetics. It is a comprehensive medication risk management tool powered by data, analytics and scientific research. - May 02, 2017 - Emgenex
StandUpKids is announcing the 10 teachers that are winners of $5000 grants for standing desks as part of their partnership with Michelle Obama's Let's Move! Active Schools movement. - April 13, 2017 - StandUpKids
Clinical Support Services Inc. (CSS), an industry leader in the delivery of Medication Therapy Management (MTM) software and services, announced the addition of Leslie Lotano-Saba as Chief Operating Officer. In this role, Leslie provides operational and strategic leadership, manages day to day operations... - April 06, 2017 - Clinical Support Services, Inc.
eDoc4U, a leading provider of population health management and provider solutions, announced today it has been certified for a third time by the National Committee for Quality Assurance (NCQA). - March 28, 2017 - eDoc4U
SA-BRC is pleased to announce the initiation of research on "Global Antidiabetic Drugs Market." - March 26, 2017 - SA-BRC
Gilad&Gilad, the health science company is presently relocating its headquarters to Henderson (a suburb of Las Vegas), Nevada, expecting growth of its dietary supplements products, AgmaSet® and AgmaVet(TM), for nerve health. - February 28, 2017 - Gilad&Gilad
Hemoglobin A1c Testing Devices Market by Technologies (Boronate Affinity Chromatography, Direct Enzymatic Assay, Immunoassay, Ion-Exchange HPLC, Micro-Optical Detection Method, Capillary Electrophoresis) and End Users (Laboratory Testing Devices, Point-of-Care Testing Devices) 2016-2020 - February 28, 2017 - iHealthcareAnalyst, Inc.
Diabetes can be described as a disease, which is marked by high levels of blood glucose resulting from defects in insulin production and insulin action. The disease has become a global epidemic leading to serious complications and ultimately resulting in premature death. Diabetes affects several organs of the body including eyes, kidneys, heart. - February 25, 2017 - Market Research Hub
Founder and CEO of dailyRD, Amy Sullivan joins an elite group of professionals committed to excellence in the treatment of eating disorders. - February 21, 2017 - dailyRD
Diabetes Drugs and Devices Market by Drug Type (Oral, Injectable, Non-Injectable Drugs) and Diagnostic Devices Type 2016-2020 - February 14, 2017 - iHealthcareAnalyst, Inc.
Report provides a brief introduction of T2DM disease along with its causes, symptoms and diagnosis. It also provides details of the clinical benchmarks set by the current market landscape and also some of the expected changes to these trials along with the treatment algorithm which has been displayed. - February 11, 2017 - Market Research Hub
Report designed to provide a digestible summary of clinical characteristics, along with complete information on all last stage clinical trial results for products in the T1DM market and late-stage pipeline. Furthermore, an analysis of the clinical standards set by the current market landscape and the estimated changes about to happen to these benchmarks is also offered. - February 08, 2017 - Market Research Hub
Continuous Glucose Monitoring Market by Device Type (Guardian Real Time CGM System, Freestyle Navigator, Dexcom Seven Plus CGM System, Dexcom G4 Platinum, Minimed Paradigm Revel, Veo System) 2016-2020. - February 03, 2017 - iHealthcareAnalyst, Inc.
The grant will be used to establish a diabetes self-management education program (DSME) to teach patients with poorly controlled diabetes the lifestyle changes necessary to manage the condition. - January 29, 2017 - South Nassau Communities Hospital
One of the country’s largest diabetes EXPOs returns to Jacob K. Javits Center on March 11. - January 26, 2017 - American Diabetes Association, Bridgewater, NJ
Report provides comprehensive information on the therapeutics under development for Type 1 Diabetes (Juvenile Diabetes), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. - December 10, 2016 - Market Research Hub
The Bioscience Americas science team has a 5-year, 76% remission rate treating Type 1 diabetes using a patient's own stem cells. - December 08, 2016 - Bioscience Americas
Second study will focus on benefits of removing toxic metal pollutants in patients with diabetes and a prior heart attack. - December 07, 2016 - The Cardiac & Vascular Institute
The global human insulin market is estimated to reach USD 32.8 Billion in 2020, expanding at a CAGR of 4.8% from 2016 to 2020, published by iHealthcareAnalyst, Inc. - December 04, 2016 - iHealthcareAnalyst, Inc.
Proven solutions make medical devices safer, more reliable and improves time-to-market. Powerful technology solutions will be integrated with the General Infusion Pump (GIP) to assist in standardizing performance measurement, event monitoring and reporting. - November 30, 2016 - MedLogiq
Report provides comprehensive information on the therapeutics under development for Diabetic Neuropathic Pain, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. - November 29, 2016 - Market Research Hub
Astero® is indicated for painful wounds such as stage I-IV pressure ulcers, Venous stasis ulcers, ulcerations caused by mixed vascular etiologies, Diabetic skin ulcers, first and second degree burns, post-surgical incisions, cuts and abrasions. Astero® is specifically formulated to create a moist healing environment, which promotes granulation, epithelialization, and autolytic debridement, while providing prolonged anesthesia of the wound, lessening the need for systemic pain medications. - November 19, 2016 - Gensco Pharma
Diabetes is one of the leading causes of disability and death in the United States. “We strive to educate our patients on their concerns of diabetes, provide the latest technology in medical and conservative treatment options for their disorders; and become not only their healthcare professional but also their friend,” said Dr. Robert E. Neville.” - November 10, 2016 - Neville Foot & Ankle Centers
Free blood pressure and eye checks will also be given; Highly subsidised diabetic foot screening will be available; Nutrition talks on preventing diabetes will be held for public - November 10, 2016 - SATA CommHealth
ALPCO has released its new STELLUX® Chemiluminescent Ultrasensitive Active GLP-1 ELISA, the most sensitive active GLP-1 assay on the market. - November 09, 2016 - ALPCO
The Aid & Attendance Benefit has been one of the VA’s best kept secrets. Only a fraction of the eligible veterans over age 65, and their spouses, know about the availability of the Aid & Attendance Pension (A&A) which help elderly veterans and widows pay for home care and long term... - October 18, 2016 - Miami Valley Homecare
Dr. Leslie Miller backs the creation of a Registry of Cell Therapy to provide guidelines for stem cell use in therapies and treatments. - October 17, 2016 - Bioscience Americas
The team of Toll Brothers and Parker Adventist Hospital raised more than $5,500, matched with $5,500 in EMT services, at the recent Tour de Cure Colorado for the American Diabetes Association. - October 14, 2016 - Toll Brothers Colorado
Retinal Consultants of Arizona (RCA) – one of the nation’s leading Retina & Vitreous clinical research and patient treatment facilities – announces the opening of a 35,000 sq. foot clinical, surgical and research facility to continue addressing the growing number of Arizonans dealing with retina related disease such as age-related macular degeneration and diabetic eye disease – both are leading causes of blindness nationally. - October 13, 2016 - Retinal Consultants of Arizona
ALPCO has released new and improved versions of their Total Adiponectin and HMW & Total Adiponectin ELISAs which allow researchers to confidently measure adiponectin for the study of high molecular weight (HMW) to total ratios. - August 17, 2016 - ALPCO
Users of third party diabetes apps that connect with Apple HealthKit can now use Vigilant to be notified in advance of periods of risk.
InSpark Technologies, Inc announced that Vigilant, a smartphone-based companion to diabetes monitoring that can analyze blood glucose values and notify people in advance... - August 09, 2016 - InSpark Technologies